August 14th 2025
Irina Mazur spoke to Dermatology Times about the latest partnership, which aims to bridge the gap between clinical advice and patient behavior through personalized sun protection guidance.
Three resurfacing modalities may prevent, delay nonmelanoma skin cancer
October 1st 2006Palo Alto, Calif. - The first systematic comparison of CO2 laser, trichloroacetic acid (TCA) peels and 5 percent fluorouracil (5FU) cream as nonmelanoma skin cancer (NMSC) prophylactics suggests all three may be beneficial, though patients tolerated TCA peels best, says the study's lead author.
Lip enhancement: What product to use
October 1st 2006National report - There are several methods of lip augmentation at the disposal of the dermatologist for achieving ?sthetically desired lips in patients, including fillers, implants, resurfacing techniques (e.g. dermabrasions, peelings, lasers) botulinum toxin injections, as well as surgery.
New fillers promising but concerns remain
October 1st 2006National report - Promising new temporary fillers will give dermatologists creative new options for combinations, but for some, semi-permanent fillers won't be among them, as many remain highly skittish over unresolved problems and safety issues.
New generation HA-based filler improves results
October 1st 2006National report - Results of a pivotal study evaluating a new generation hyaluronic acid (HA)-based gel filler (Juv?derm, Allergan) for correction of nasolabial folds show that all three formulations of the injectable product provide significantly greater and longer-lasting improvement than crosslinked bovine collagen (Zyplast, Allergan) reports Leslie Baumann, M.D.
Phase 4 study reaffirms safety of low-dose acitretin
September 1st 2006Results of a phase 4, open-label, multicenter study indicate that low-dose acitretin (Soriatane, Connetics) in moderate to severe psoriasis patients provides efficacy as monotherapy by 24 weeks, but requires patience, said Gerald G. Krueger, M.D., at the American Academy of Dermatology's Academy '06.